Feb 05, 2025 / 08:00AM GMT
Fredrik Dalborg - AddLife AB - President, Chief Executive Officer
Good morning and welcome everyone to the AddLife AB 4th quarter presentation and we will take you through today and an overview of the quarter and the outlook for the future. And then after, of course, the presentation we will have a Q&A session, but as usual we have recorded a great video of a of a company within the group and this this time around it's triola so I encourage you all to stay home to watch that video of a fantastic company within the lab tech business area.
AddLife was able to finish 2024 in a very strong way. The company performed really well, driven by healthy customer demand, but also diligent work on the business fundamentals, improving efficiency and profitability continuously, and this is again an important piece of the ad life DNA.
Sales increased by 11%, quite healthy development, organic and currency adjusted the growth was 9%. In lab tech we saw strong instrument sales after a bit of a weakness in Q3 2024 and also a very healthy invoicing and sales development in Eastern Europe. On the medtech
Full Year 2024 AddLife AB Earnings Call Transcript
Feb 05, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers